Share Price and Basic Stock Data
Last Updated: January 28, 2026, 8:40 pm
| PEG Ratio | -1.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Excel Industries Ltd operates in the agrochemicals and pesticides sector, focusing on providing innovative solutions to enhance agricultural productivity. As of the latest reports, the company’s stock price stood at ₹914 with a market capitalization of ₹1,148 Cr. The company recorded total sales of ₹1,090 Cr for the fiscal year ending March 2023, reflecting a decline from ₹1,178 Cr in the previous fiscal year. Revenue from operations showed fluctuations in quarterly results, with sales peaking at ₹312 Cr in September 2022, but subsequently declining to ₹198 Cr by September 2023. The trailing twelve months (TTM) revenue was reported at ₹1,024 Cr, indicating a need for strategic initiatives to stabilize and grow revenue. Excel’s ability to manage production costs effectively will be crucial in navigating these revenue challenges, especially considering the competitive landscape in the agrochemical sector.
Profitability and Efficiency Metrics
Profitability metrics for Excel Industries reveal a mixed performance. The company’s net profit for the fiscal year ending March 2023 was ₹80 Cr, down from ₹161 Cr in the previous year, resulting in a net profit margin of 7.33%. The operating profit margin (OPM) has also shown volatility, recorded at 12% for the year ending March 2023 but declining to a mere 1% by September 2023. The interest coverage ratio (ICR) stood impressively at 63.24x, indicating strong capacity to meet interest obligations, while return on equity (ROE) remained modest at 5.21%. The cash conversion cycle (CCC) averaged 49 days, suggesting effective management of working capital. Despite these strengths, the low OPM points to potential inefficiencies, particularly in cost management and pricing strategies, which may need to be addressed to enhance overall profitability.
Balance Sheet Strength and Financial Ratios
Excel Industries maintains a robust balance sheet with total assets amounting to ₹1,920 Cr as of March 2025, against total liabilities of ₹1,920 Cr, indicating a debt-free status with borrowings at ₹11 Cr. The company reported reserves of ₹1,802 Cr, reflecting a solid financial foundation. The price-to-book value (P/BV) ratio is low at 0.76x, suggesting that the stock may be undervalued compared to its book value of ₹1,263.84 per share. The current ratio stood at 3.19, demonstrating strong liquidity, while the quick ratio was at 2.65, indicating efficient short-term financial health. However, the declining return on capital employed (ROCE) at 7.11% raises concerns about the efficiency of capital utilization. Overall, while the balance sheet is strong, the efficiency ratios suggest room for improvement in capital deployment.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Excel Industries indicates a stable promoter holding of 52.68%, which reflects confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) hold 2.01% of the shares, while domestic institutional investors (DIIs) account for 7.06%. The public holds 38.27%, with a total of 22,593 shareholders as of the latest report. Over recent quarters, there has been minimal fluctuation in shareholding, with promoters consistently maintaining their stake. The relatively low FII participation may suggest limited international confidence, which could be a concern for future capital raising efforts. However, the consistent DII presence indicates some level of institutional support. This stable shareholding structure could be a positive aspect for investors looking for long-term value.
Outlook, Risks, and Final Insight
Looking ahead, Excel Industries faces a dual challenge of stabilizing revenue while enhancing profitability. Key strengths include a solid balance sheet with low debt and strong liquidity ratios, providing a buffer against market volatility. However, risks include declining sales trends and fluctuating profit margins, which could hinder growth if not addressed. Additionally, increasing competition in the agrochemical sector may pressure margins further. The company’s ability to innovate and adapt to market demands will be crucial in mitigating these risks. Potential scenarios could involve a recovery in sales through new product launches or strategic partnerships, while failure to address operational inefficiencies may lead to continued profit declines. Stakeholders should monitor these developments closely to gauge the company’s future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 4,504 Cr. | 1,046 | 2,114/1,039 | 11.2 | 487 | 0.57 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 758 Cr. | 225 | 391/165 | 15.6 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 55.5 Cr. | 106 | 149/56.6 | 9.94 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,673 Cr. | 206 | 331/198 | 101 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 741 Cr. | 20.9 | 35.8/16.3 | 57.9 | 22.8 | 0.96 % | 12.9 % | 9.95 % | 1.00 |
| Industry Average | 10,464.05 Cr | 1,068.73 | 29.08 | 369.04 | 0.46% | 15.21% | 19.87% | 6.67 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 312 | 223 | 226 | 214 | 198 | 180 | 234 | 265 | 269 | 196 | 248 | 310 | 270 |
| Expenses | 279 | 195 | 215 | 207 | 195 | 179 | 221 | 226 | 220 | 184 | 228 | 267 | 240 |
| Operating Profit | 33 | 28 | 11 | 8 | 3 | 1 | 12 | 39 | 49 | 12 | 20 | 42 | 30 |
| OPM % | 10% | 13% | 5% | 4% | 1% | 1% | 5% | 15% | 18% | 6% | 8% | 14% | 11% |
| Other Income | 6 | 2 | 3 | 9 | 7 | 11 | 5 | 11 | 8 | 5 | 6 | 12 | 7 |
| Interest | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| Depreciation | 8 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 |
| Profit before tax | 30 | 22 | 5 | 8 | 2 | 4 | 9 | 41 | 47 | 8 | 16 | 44 | 27 |
| Tax % | 25% | 14% | 57% | 24% | 9% | 34% | 25% | 25% | 24% | 26% | 24% | 24% | 23% |
| Net Profit | 22 | 19 | 2 | 6 | 2 | 3 | 7 | 31 | 36 | 6 | 12 | 34 | 21 |
| EPS in Rs | 17.53 | 14.86 | 1.72 | 4.68 | 1.42 | 2.13 | 5.31 | 24.68 | 28.38 | 4.93 | 9.87 | 26.86 | 16.86 |
Last Updated: January 1, 2026, 8:03 pm
Below is a detailed analysis of the quarterly data for Excel Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 270.00 Cr.. The value appears to be declining and may need further review. It has decreased from 310.00 Cr. (Jun 2025) to 270.00 Cr., marking a decrease of 40.00 Cr..
- For Expenses, as of Sep 2025, the value is 240.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 267.00 Cr. (Jun 2025) to 240.00 Cr., marking a decrease of 27.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Jun 2025) to 30.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Sep 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Jun 2025) to 11.00%, marking a decrease of 3.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Jun 2025) to 27.00 Cr., marking a decrease of 17.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Jun 2025) to 23.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Jun 2025) to 21.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 16.86. The value appears to be declining and may need further review. It has decreased from 26.86 (Jun 2025) to 16.86, marking a decrease of 10.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 416 | 482 | 448 | 462 | 599 | 825 | 702 | 749 | 1,178 | 1,090 | 826 | 978 | 1,024 |
| Expenses | 376 | 409 | 385 | 419 | 474 | 574 | 571 | 628 | 946 | 961 | 801 | 857 | 920 |
| Operating Profit | 40 | 72 | 63 | 44 | 125 | 250 | 131 | 122 | 232 | 129 | 25 | 121 | 104 |
| OPM % | 10% | 15% | 14% | 9% | 21% | 30% | 19% | 16% | 20% | 12% | 3% | 12% | 10% |
| Other Income | 5 | 7 | 3 | 9 | 4 | 5 | 10 | 9 | 15 | 12 | 32 | 29 | 31 |
| Interest | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 3 | 4 | 2 |
| Depreciation | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 | 34 | 35 |
| Profit before tax | 21 | 51 | 38 | 27 | 107 | 234 | 115 | 101 | 213 | 106 | 23 | 113 | 97 |
| Tax % | 15% | 19% | 31% | 26% | 31% | 34% | 16% | 29% | 24% | 24% | 25% | 24% | |
| Net Profit | 18 | 41 | 26 | 20 | 74 | 153 | 96 | 71 | 161 | 80 | 17 | 85 | 74 |
| EPS in Rs | 16.50 | 34.59 | 20.18 | 15.93 | 58.78 | 122.07 | 76.42 | 56.55 | 128.23 | 63.59 | 13.53 | 67.86 | 58.52 |
| Dividend Payout % | 23% | 20% | 22% | 38% | 21% | 15% | 13% | 20% | 18% | 18% | 41% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 127.78% | -36.59% | -23.08% | 270.00% | 106.76% | -37.25% | -26.04% | 126.76% | -50.31% | -78.75% | 400.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -164.36% | 13.51% | 293.08% | -163.24% | -144.01% | 11.21% | 152.80% | -177.07% | -28.44% | 478.75% |
Excel Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | -6% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -4% |
| 3 Years: | -21% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 7% |
| 3 Years: | -5% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 7% |
| 3 Years: | 4% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 147 | 180 | 204 | 404 | 526 | 693 | 695 | 845 | 1,143 | 1,235 | 1,421 | 1,582 | 1,802 |
| Borrowings | 102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | 12 | 11 |
| Other Liabilities | 97 | 106 | 121 | 141 | 186 | 209 | 212 | 251 | 330 | 248 | 367 | 319 | 434 |
| Total Liabilities | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 | 2,253 |
| Fixed Assets | 128 | 158 | 164 | 183 | 203 | 238 | 376 | 389 | 427 | 428 | 428 | 459 | 456 |
| CWIP | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 19 | 13 | 29 |
| Investments | 22 | 23 | 27 | 211 | 282 | 394 | 264 | 365 | 547 | 625 | 984 | 1,085 | 1,280 |
| Other Assets | 181 | 204 | 227 | 216 | 220 | 272 | 287 | 340 | 492 | 421 | 365 | 364 | 488 |
| Total Assets | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 | 1,920 | 2,253 |
Below is a detailed analysis of the balance sheet data for Excel Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,802.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,582.00 Cr. (Mar 2025) to 1,802.00 Cr., marking an increase of 220.00 Cr..
- For Borrowings, as of Sep 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 434.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 319.00 Cr. (Mar 2025) to 434.00 Cr., marking an increase of 115.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,253.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,920.00 Cr. (Mar 2025) to 2,253.00 Cr., marking an increase of 333.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 456.00 Cr.. The value appears to be declining and may need further review. It has decreased from 459.00 Cr. (Mar 2025) to 456.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 16.00 Cr..
- For Investments, as of Sep 2025, the value is 1,280.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,085.00 Cr. (Mar 2025) to 1,280.00 Cr., marking an increase of 195.00 Cr..
- For Other Assets, as of Sep 2025, the value is 488.00 Cr.. The value appears strong and on an upward trend. It has increased from 364.00 Cr. (Mar 2025) to 488.00 Cr., marking an increase of 124.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,253.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,920.00 Cr. (Mar 2025) to 2,253.00 Cr., marking an increase of 333.00 Cr..
Notably, the Reserves (1,802.00 Cr.) exceed the Borrowings (11.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -23.00 | -26.00 | -24.00 | 115.00 | 243.00 | 107.00 | 113.00 | 225.00 | 126.00 | 23.00 | 109.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 89 | 80 | 103 | 95 | 76 | 70 | 78 | 84 | 62 | 52 | 82 | 81 |
| Inventory Days | 74 | 103 | 99 | 86 | 79 | 75 | 90 | 71 | 103 | 78 | 80 | 70 |
| Days Payable | 81 | 84 | 112 | 98 | 123 | 108 | 122 | 126 | 112 | 64 | 139 | 102 |
| Cash Conversion Cycle | 82 | 99 | 90 | 83 | 32 | 36 | 46 | 29 | 52 | 67 | 23 | 49 |
| Working Capital Days | 17 | 28 | 27 | 42 | 50 | 57 | 49 | 51 | 61 | 61 | 47 | 58 |
| ROCE % | 15% | 24% | 18% | 10% | 22% | 38% | 17% | 13% | 21% | 9% | 2% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 67.87 | 13.53 | 63.59 | 128.24 | 56.55 |
| Diluted EPS (Rs.) | 67.87 | 13.53 | 63.59 | 128.24 | 56.55 |
| Cash EPS (Rs.) | 94.97 | 38.53 | 88.54 | 152.62 | 78.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1263.84 | 1135.23 | 987.82 | 914.32 | 677.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1263.84 | 1135.23 | 987.82 | 914.32 | 677.41 |
| Revenue From Operations / Share (Rs.) | 778.06 | 657.20 | 866.96 | 937.12 | 596.21 |
| PBDIT / Share (Rs.) | 119.16 | 45.07 | 111.10 | 195.73 | 103.53 |
| PBIT / Share (Rs.) | 92.06 | 20.07 | 86.16 | 171.35 | 81.93 |
| PBT / Share (Rs.) | 89.85 | 18.02 | 84.14 | 169.80 | 80.19 |
| Net Profit / Share (Rs.) | 67.87 | 13.53 | 63.59 | 128.24 | 56.55 |
| NP After MI And SOA / Share (Rs.) | 67.87 | 13.53 | 63.59 | 128.24 | 56.55 |
| PBDIT Margin (%) | 15.31 | 6.85 | 12.81 | 20.88 | 17.36 |
| PBIT Margin (%) | 11.83 | 3.05 | 9.93 | 18.28 | 13.74 |
| PBT Margin (%) | 11.54 | 2.74 | 9.70 | 18.11 | 13.45 |
| Net Profit Margin (%) | 8.72 | 2.05 | 7.33 | 13.68 | 9.48 |
| NP After MI And SOA Margin (%) | 8.72 | 2.05 | 7.33 | 13.68 | 9.48 |
| Return on Networth / Equity (%) | 5.36 | 1.19 | 6.43 | 14.02 | 8.34 |
| Return on Capital Employeed (%) | 6.62 | 1.58 | 7.90 | 16.77 | 10.79 |
| Return On Assets (%) | 4.44 | 0.94 | 5.35 | 10.84 | 6.39 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 0.52 | 0.50 | 0.73 | 0.90 | 0.73 |
| Current Ratio (X) | 3.19 | 2.56 | 3.63 | 2.36 | 2.09 |
| Quick Ratio (X) | 2.65 | 2.03 | 2.56 | 1.55 | 1.65 |
| Inventory Turnover Ratio (X) | 9.76 | 4.09 | 4.14 | 5.31 | 4.90 |
| Dividend Payout Ratio (NP) (%) | 8.10 | 83.13 | 35.38 | 8.77 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.79 | 29.19 | 25.41 | 7.37 | 0.00 |
| Earning Retention Ratio (%) | 91.90 | 16.87 | 64.62 | 91.23 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.21 | 70.81 | 74.59 | 92.63 | 0.00 |
| Interest Coverage Ratio (X) | 63.24 | 30.16 | 64.23 | 126.97 | 59.73 |
| Interest Coverage Ratio (Post Tax) (X) | 37.19 | 10.43 | 37.93 | 84.18 | 33.63 |
| Enterprise Value (Cr.) | 1202.14 | 878.57 | 914.63 | 1660.75 | 1011.14 |
| EV / Net Operating Revenue (X) | 1.23 | 1.06 | 0.83 | 1.41 | 1.35 |
| EV / EBITDA (X) | 8.03 | 15.51 | 6.55 | 6.75 | 7.77 |
| MarketCap / Net Operating Revenue (X) | 1.25 | 1.08 | 0.91 | 1.46 | 1.41 |
| Retention Ratios (%) | 91.89 | 16.86 | 64.61 | 91.22 | 0.00 |
| Price / BV (X) | 0.76 | 0.62 | 0.80 | 1.50 | 1.24 |
| Price / Net Operating Revenue (X) | 1.25 | 1.08 | 0.91 | 1.46 | 1.41 |
| EarningsYield | 0.07 | 0.01 | 0.07 | 0.09 | 0.06 |
After reviewing the key financial ratios for Excel Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 67.87. This value is within the healthy range. It has increased from 13.53 (Mar 24) to 67.87, marking an increase of 54.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 67.87. This value is within the healthy range. It has increased from 13.53 (Mar 24) to 67.87, marking an increase of 54.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 94.97. This value is within the healthy range. It has increased from 38.53 (Mar 24) to 94.97, marking an increase of 56.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,263.84. It has increased from 1,135.23 (Mar 24) to 1,263.84, marking an increase of 128.61.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,263.84. It has increased from 1,135.23 (Mar 24) to 1,263.84, marking an increase of 128.61.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 778.06. It has increased from 657.20 (Mar 24) to 778.06, marking an increase of 120.86.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 119.16. This value is within the healthy range. It has increased from 45.07 (Mar 24) to 119.16, marking an increase of 74.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 92.06. This value is within the healthy range. It has increased from 20.07 (Mar 24) to 92.06, marking an increase of 71.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.85. This value is within the healthy range. It has increased from 18.02 (Mar 24) to 89.85, marking an increase of 71.83.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 67.87. This value is within the healthy range. It has increased from 13.53 (Mar 24) to 67.87, marking an increase of 54.34.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 67.87. This value is within the healthy range. It has increased from 13.53 (Mar 24) to 67.87, marking an increase of 54.34.
- For PBDIT Margin (%), as of Mar 25, the value is 15.31. This value is within the healthy range. It has increased from 6.85 (Mar 24) to 15.31, marking an increase of 8.46.
- For PBIT Margin (%), as of Mar 25, the value is 11.83. This value is within the healthy range. It has increased from 3.05 (Mar 24) to 11.83, marking an increase of 8.78.
- For PBT Margin (%), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 2.74 (Mar 24) to 11.54, marking an increase of 8.80.
- For Net Profit Margin (%), as of Mar 25, the value is 8.72. This value is within the healthy range. It has increased from 2.05 (Mar 24) to 8.72, marking an increase of 6.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.72. This value is within the healthy range. It has increased from 2.05 (Mar 24) to 8.72, marking an increase of 6.67.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.36. This value is below the healthy minimum of 15. It has increased from 1.19 (Mar 24) to 5.36, marking an increase of 4.17.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.62. This value is below the healthy minimum of 10. It has increased from 1.58 (Mar 24) to 6.62, marking an increase of 5.04.
- For Return On Assets (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 5. It has increased from 0.94 (Mar 24) to 4.44, marking an increase of 3.50.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.50 (Mar 24) to 0.52, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 2.56 (Mar 24) to 3.19, marking an increase of 0.63.
- For Quick Ratio (X), as of Mar 25, the value is 2.65. This value exceeds the healthy maximum of 2. It has increased from 2.03 (Mar 24) to 2.65, marking an increase of 0.62.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.76. This value exceeds the healthy maximum of 8. It has increased from 4.09 (Mar 24) to 9.76, marking an increase of 5.67.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 20. It has decreased from 83.13 (Mar 24) to 8.10, marking a decrease of 75.03.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.79. This value is below the healthy minimum of 20. It has decreased from 29.19 (Mar 24) to 5.79, marking a decrease of 23.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.90. This value exceeds the healthy maximum of 70. It has increased from 16.87 (Mar 24) to 91.90, marking an increase of 75.03.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.21. This value exceeds the healthy maximum of 70. It has increased from 70.81 (Mar 24) to 94.21, marking an increase of 23.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 63.24. This value is within the healthy range. It has increased from 30.16 (Mar 24) to 63.24, marking an increase of 33.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 37.19. This value is within the healthy range. It has increased from 10.43 (Mar 24) to 37.19, marking an increase of 26.76.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,202.14. It has increased from 878.57 (Mar 24) to 1,202.14, marking an increase of 323.57.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has increased from 1.06 (Mar 24) to 1.23, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 8.03. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 8.03, marking a decrease of 7.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has increased from 1.08 (Mar 24) to 1.25, marking an increase of 0.17.
- For Retention Ratios (%), as of Mar 25, the value is 91.89. This value exceeds the healthy maximum of 70. It has increased from 16.86 (Mar 24) to 91.89, marking an increase of 75.03.
- For Price / BV (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.62 (Mar 24) to 0.76, marking an increase of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has increased from 1.08 (Mar 24) to 1.25, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.07, marking an increase of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Excel Industries Ltd:
- Net Profit Margin: 8.72%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.62% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.36% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 37.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.4 (Industry average Stock P/E: 29.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.72%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 184-87, Swami Vivekanand Road, Mumbai Maharashtra 400102 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. G Narayana | Chairman Emeritus |
| Mr. Ashwin C Shroff | Executive Chairman |
| Mr. Ravi A Shroff | Managing Director |
| Mr. Hrishit A Shroff | Executive Director |
| Mr. Ninad Gupte | Independent Director |
| Mr. Shekhar Khanolkar | Independent Director |
| Mr. Rajesh Varma | Independent Director |
| Mr. Vihang Virkar | Independent Director |
| Dr. Meena A Galliara | Independent Director |
| Mr. Dinesh Bhagat | Nominee Director |
FAQ
What is the intrinsic value of Excel Industries Ltd?
Excel Industries Ltd's intrinsic value (as of 29 January 2026) is ₹800.98 which is 11.49% lower the current market price of ₹905.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,133 Cr. market cap, FY2025-2026 high/low of ₹1,440/798, reserves of ₹1,802 Cr, and liabilities of ₹2,253 Cr.
What is the Market Cap of Excel Industries Ltd?
The Market Cap of Excel Industries Ltd is 1,133 Cr..
What is the current Stock Price of Excel Industries Ltd as on 29 January 2026?
The current stock price of Excel Industries Ltd as on 29 January 2026 is ₹905.
What is the High / Low of Excel Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Excel Industries Ltd stocks is ₹1,440/798.
What is the Stock P/E of Excel Industries Ltd?
The Stock P/E of Excel Industries Ltd is 15.4.
What is the Book Value of Excel Industries Ltd?
The Book Value of Excel Industries Ltd is 1,438.
What is the Dividend Yield of Excel Industries Ltd?
The Dividend Yield of Excel Industries Ltd is 1.52 %.
What is the ROCE of Excel Industries Ltd?
The ROCE of Excel Industries Ltd is 7.11 %.
What is the ROE of Excel Industries Ltd?
The ROE of Excel Industries Ltd is 5.21 %.
What is the Face Value of Excel Industries Ltd?
The Face Value of Excel Industries Ltd is 5.00.